|
Pages |
Type of Article |
Article title |
Authors
(corresponding author in boldface)
|
File / Viewing options |
|
1-9 |
Research
Article |
Intraarterial chemotherapy and chemoembolization in head and neck
cancer. Establishment as a neoadjuvant routine method |
Adorj΅n
F. Kovacs
|
HTML |
|
11-19 |
Review
Article |
Current aspects in the treatment of patients with relapsed or
refractory testicular cancer |
Oliver Rick, Jörg Beyer, Thomas Braun, Kurt Possinger, Wolfgang Siegert
|
HTML |
|
21-29 |
Research
Article |
Gene expression profiles related with overcoming cisplatin resistance
in human cancer cell lines |
Moonkyu Kim, Young Jin Park, Ok Ju Kim, Gab Yong
Lee, Eun Jung Chung, Young Kwan Sung, Jung Chul Kim, Insook Han, Youn Soo Sohn
|
HTML |
|
31-37 |
Research
Article |
Vascular endothelial growth factor modulates cisplatin sensitivity in
human ovarian carcinoma cells |
Guodong Hu, Sean Ryan, Yunfeng Zhu, Eddie Reed,
Xiping Li, Gangduo Wang, and Qingdi Q.
Li
|
HTML |
|
39-46 |
Research
Article |
Overexpression of angiogenic growth factors in lung cancer cells is
associated with cisplatin resistance |
Xiping Li, Xuyi Liu, Jie Wang, Zengli Wang, Wei
Jiang, Eddie Reed, Yi Zhang, Yuanlin Liu, and Qingdi Q. Li
|
HTML |
|
47-61 |
Review
Article |
Cisplatin nephrotoxicity: molecular mechanisms |
Marie H. Hanigan and Prasad Devarajan
|
HTML |
|
63-70 |
Research
Article |
Mitoxantrone, prednisone, pentostatin and bleomycin for patients with
indolent non-Hodgkin's lymphoma relapsed or unresponsive to previous
treatments. Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (GISL) |
Massimo
Federico,
Vincenzo Callea, Romano Danesi, Antonella Montanini, Nicola Di Renzo, Mario
Petrini, Mario Del Tacca, Maria Angela Sirotti, Giovanni Santacroce, Alberto
Bagnulo, Matteo Dell'Olio and Maura Brugiatelli for GISL
|
HTML |
|
71-79 |
Review
Article |
Chemotherapy in elderly
patients with advanced breast cancer |
Giuseppe Colantuoni, Antonio Rossi, Carmine
Ferrara, Dario Nicolella, Filomena Del Gaizo, Ciro Guerriero, Giuseppe
Airoma, Maria Luisa Barzelloni, Paolo Maione, Vincenzo Salerno, Cesare Gridelli
|
HTML |
|
81-91 |
Review
Article |
Drug resistance in breast cancer |
Hermann Lage
|
HTML |
|
93-101 |
Review
Article |
Screening for lung cancer: a review and current status |
Debora S. Bruno and William Tester
|
HTML |
|
103-107 |
Research
Article |
Expression of RB1CC1, a novel tumor suppressor gene, is inversely
correlated with the Ki-67 proliferation index in primary breast cancers |
Koji Teramoto, Tokuhiro Chano, Yoshitomo Ozaki,
Satoru Sawai, Noriaki Tezuka, Keiichi
Kontani, Shozo Fujino, Hidetoshi Okabe
|
HTML |
|
109-120 |
Research
Article |
Approaches to the treatment of brain tumors using cytokine-secreting
allogeneic fibroblasts |
Terry
Lichtor,
Roberta P Glick, Edward P Cohen
|
HTML |
|
121-131 |
Research
Article |
Safety, feasibility and clinical benefit of localized chemotherapy
using microencapsulated cells for inoperable pancreatic carcinoma in a phase
I/II trial |
Matthias
Löhr,
Jens-Christian Kröger, Anne Hoffmeyer, Mathias Freund, Johannes Hain,
Albrecht Holle, Wolfram T. Knöfel, Stefan Liebe, Horst Nizze, Matthias
Renner, Robert Saller, Petra Müller, Thomas Wagner, Karlheinz Hauenstein,
Brian Salmons and Walter H. Günzburg
|
HTML |
|
133-142 |
Review
Article |
Electrochemotherapy: advantages and drawbacks in treatment of cancer
patients |
Gregor Sersa, Maja Cemazar, and
Zvonimir Rudolf
|
HTML |
|
143-151 |
Research
Article |
p16 downregulates VEGF and inhibits angiogenesis in breast cancer cells |
Yi Lu, Jun Zhang, Derrick J.
Beech, Linda K. Myers, and Lisa K. Jennings
|
HTML |
|
153-162 |
Research
Article |
Basic fibroblast growth factor antisense oligonucleotides inhibit
renal cell carcinoma cell growth and angiogenesis |
Wenyin Shi and Dietmar W. Siemann
|
HTML |
|
163-171 |
Review
Article |
Antitumoral cell-based therapies |
Javier
Garc£a-Castro, Daniel Rubio, Ricardo de la Fuente, Antonio Bernad
|
HTML |
|
173-178 |
Research
Article |
Can mortalin be a candidate target for cancer therapy? |
Renu Wadhwa, Kazunari Taira and Sunil
C Kaul
|
HTML |
|
179-190 |
Review
Article / Hypothesis |
Therapeutic potential of antinuclear autoantibodies in cancer |
Vladimir P.
Torchilin,
Leonid Z. Iakoubov, Zeev Estrov
|
HTML |
|
191-196 |
Research
Article |
Filgrastim use: evaluation in cancer and critically ill non- cancer
patients |
Yolande B.
Saab,
Leyla Sharaf, Ismail Zeidan, Abdelrahman Bizri
|
HTML |
|
197-202 |
Research
Article |
Gemcitabine, cisplatin, fluorouracil and folinic acid as first line
treatment of locally advanced and/or metastatic pancreatic cancer: a phase II
study of the gruppo oncologico dell'Italia meridionale (G.O.I.M.) |
Vittorio
Gebbia,
Francesco Giuliani, Generoso Uomo, Evaristo Maiello, Maria Rosaria Valerio,
Nicolo Borsellino, Nicol‰ Gebbia, Giuseppe Colucci
|
HTML |
|
203-208 |
Research
Article |
Phase I study of high dose 5-fluorouracil and folinic acid in weekly
continuous infusions |
Jean-Marc
Limacher,
Bernard Duclos, Patrick Dufour, Jean-Marie Wihlm, Dominique Leveque, François
Jehl, François Eichler, Roger Keiling, Shanti Natarajan-Ame, Jean-Emmanuel Kurtz,
Jean-Pierre Bergerat
|
HTML |
|
209-213 |
Research
Article |
High-dose methotrexate with citrovorum factor for malignant fibrous
histiocytoma of soft tissue: a cell culture study |
Toshiaki Hitora, Takashi Marui, Tetsuji Yamamoto, Toshihiro Akisue, Teruya
Kawamoto, Keiko Nagira, Tetsuya Nakatani, Shinichi Yoshiya, Masahiro Kurosaka
|
HTML |
|
215-221 |
Research
Article |
Phase II intergroup trial of sequential chemotherapy and radiotherapy
for AIDS-related primary central nervous system lymphoma |
Richard F Ambinder, Sandra Lee, Walter J Curran, Joseph A Sparano, Robert L Krigel,
Justin McArthur, Christopher Schultz, Carl E Freter, Leslie Kaplan, Jamie H
VonRoenn
|
HTML |
|
223-232 |
Review
Article |
Sentinel lymph node biopsy for breast cancer: addressing the
controversies |
Anees Chagpar, John Pilavas, Celia Chao, Robert
C.G. Martin II, Kelly M. McMasters
|
HTML |
|
233-236 |
Research
Article |
A randomised, double-blind, phase II study of three different
marimastat schedules administered to patients with resected Dukes C colorectal cancer |
Philippa G.
Corrie, David
J. Kerr, Kim Bennett, Charles B. Wilson, Rachel Midgley, Peter Brown
|
HTML |
|
237-244 |
Review
Article |
LY900003: A novel compound for the treatment of non-small cell lung
cancer |
Susannah E.
Motl
|
HTML |
|
245-256 |
Research
Article |
Activity of chemotherapy and immunotherapy on malignant mesothelioma:
a systematic review of the literature with meta-analysis |
Thierry
Berghmans,
Jean-Jacques Lafitte, Céline Mascaux, Anne-Pascale Meert, Marianne Paesmans
and Jean-Paul Sculier
|
HTML |
|
257-261 |
Research
Article |
Expression of insulin-like growth factors and their receptors in malignant fibrous histiocytoma of
soft tissues |
Tetsuji
Yamamoto,
Toshihiro Akisue, Tetsuya Nakatani, Takashi Marui, Ikuo Fujita, Keiji
Matsumoto, Toshiaki Hitora, Teruya Kawamoto, Keiko Nagira, Masahiro Kurosaka
|
HTML |
|
263-268 |
Review
Article |
Ethical, cultural and religious aspects of hereditary cancer in
Jewish communities |
Mark Levin
|
HTML |
|
269-273 |
Review
Article |
Selective intraarterial cisplatin chemotherapy in treatment of
advanced malignant squamous cell carcinoma of the head and neck |
Afshin
Teymoortash and Jochen A.Werner
|
HTML |
|
275-281 |
Review
Article |
Protein kinase C-d and its downstream effectors as potential targets for cancer therapy |
Jihua Liu, David Durrant and Ray M. Lee
|
HTML |
|
283-291 |
Reserach
Article |
A Phase I Safety and Imaging Study Using Radiofrequency Ablation (RFA) Followed by 131I-chTNT-1/B Radioimmunotherapy Adjuvant Treatment of Hepatic Metastases |
Peter M.
Anderson,
Gregory A. Wiseman, Bradley D. Lewis, J. William Charboneau, William L. Dunn,
Susan P. Carpenter, Terrence Chew
|
HTML |
|
293-298 |
Reserach
Article |
Allelic loss at the SEP15
locus in breast cancer |
Mohamed A. Nasr, Ya Jun Hu, and Alan M. Diamond
|
HTML |
|
299-314 |
Review
Article |
Dendritic cell based vaccines for immunotherapy of colorectal cancer |
Asim Saha, Sunil K. Chatterjee, Kartik Mohanty,
Kenneth A. Foon, Malaya
Bhattacharya-Chatterjee
|
HTML |
|
315-322 |
Review
Article |
Multitargeted antifolate (Pemetrexed): A comprehensive review of its
mechanisms of action, recent results and future prospects |
Delphine Exinger, Françoise Exinger, Bertrand Mennecier,
Jean-Marc Limacher, Patrick Dufour, Jean-Emmanuel
Kurtz
|
HTML |
|
323-333 |
Review
Article |
Molecular therapy of gastric cancer |
Jie Chen, Minhu Chen, Christoph Röcken
, Tobias Götze, Peter Malfertheiner and Matthias P.A. Ebert
|
HTML |
|
335-342 |
Review
Article |
Tumor angiogenesis as a strategy for radiosensitization |
Bo Lu, Dong W. Kim, Dennis E. Hallahan
|
HTML |
|
343-351 |
Review
Article |
p14ARF: Role in the cellular stress response
and applications to cancer |
Yinghui Huang and Ruth A. Gjerset |
HTML |
|
353-362 |
Review
Article |
The role of B lymphocytes in breast cancer: a review and current
status |
Sazini Nzula, James J. Going,
David I. Stott
|
HTML |
|
363-371 |
Review
Article |
Advances in breast cancer therapy and chemoprevention: current
strategies and new approaches |
Brittney-Shea
Herbert
|
HTML |
|
373-391 |
Review
Article |
Treatment planning
in endometrial cancer |
Angiolo Gadducci, Stefania Cosio, Andrea Riccardo Genazzani |
HTML |
|
393-405 |
Review
Article |
Dendritic cell-mediated immunosuppression in malignant melanoma |
Marta E Polak, Nicola J
Borthwick, Martine J Jager, Ian A Cree
|
HTML |